Zacks.com featured highlights JD.com, City Office REIT, Fresenius Medical Care, Itron and Enersys
Werte in diesem Artikel
For Immediate ReleaseChicago, IL – March 27, 2025 – Stocks in this week’s article are JD.com JD, City Office REIT CIO, Fresenius Medical Care FMS, Itron ITRI and Enersys ENS.5 Low Price-to-Book Stocks to Include in Your PortfolioWhen evaluating a company’s value, investors mostly look at the stock’s price-to-earnings (P/E) or price-to-sales (P/S) ratio. While P/E is the ratio of annual earnings to stock price, P/S reflects the amount investors pay for each dollar of revenues generated by the company.Though P/E and P/S valuation tools are more commonly used for stock selection, the price-to-book ratio (P/B ratio) is also an easy-to-use metric for identifying low-priced stocks with high-growth prospects.P/B is the ratio of stock price to book value.It is calculated as below:P/B ratio = market capitalization/book value of equityThe P/B ratio helps identify low-priced stocks with high growth prospects. JD.com, City Office REIT, Fresenius Medical Care, Itron and Enersys are some such stocks.Now, let us understand the concept of book value.What is Book Value?There are several ways by which book value can be defined. Book value is the total value that would be left over, according to the company’s balance sheet, if it goes bankrupt immediately. In other words, this is what shareholders would theoretically receive if a company liquidates all its assets after paying off all its liabilities.It is calculated by subtracting total liabilities from the total assets of a company. In most cases, this equates to common stockholders’ equity on the balance sheet. However, depending on the company’s balance sheet, intangible assets should also be subtracted from the total assets to determine book value.Understanding P/B RatioBy comparing the book value of equity to its market price, we get an idea of whether a company is under- or overpriced. However, like P/E or P/S ratio, it is always better to compare P/B ratios within industries.A P/B ratio of less than one means that the stock is trading at less than its book value or the stock is undervalued and, therefore, a good buy. Conversely, a stock with a ratio greater than one can be interpreted as being overvalued or relatively expensive.For example, a stock with a P/B ratio of 2 means that we pay $2 for every $1 of book value. Thus, the higher the P/B, the more expensive the stock.But there is a warning. A P/B ratio of less than one can also mean that the company is earning weak or even negative returns on its assets or that the assets are overstated. In such a case, the stock should be shunned because it may be destroying shareholder value. Conversely, the stock’s price may be significantly high — thereby pushing the P/B ratio to more than one — in the likely case that it has become a takeover target, a good enough reason to own the stock.Moreover, the P/B ratio is not without limitations. It is useful for businesses like finance, investments, insurance and banking or manufacturing companies with many liquid/tangible assets on the books. However, it can be misleading for firms with significant R&D expenditure, high debt, service companies, or those with negative earnings.In any case, the ratio is not particularly relevant as a standalone number. One should analyze other ratios like P/E, P/S and debt to equity before arriving at a reasonable investment decision.Here are five of the 12 stocks that qualified the screening:JD.com operates as an online direct sales company in China. The company, through its website www.jd.com and mobile applications, offers a selection of authentic products, including computers, mobile handsets, home appliances, automobile accessories, clothing and shoes, luxury goods, furniture and household products, personal care items, food and nutritional supplements and much more.JD presently has a Zacks Rank #1 and a Value Score of A. The company has a projected 3-5-year EPS growth rate of 32.3%.Vancouver, Canada-based City Office REIT is a real estate investment trust. It focuses on acquiring, owning and operating office properties in the United States. The company invests in properties located in metropolitan areas in the Southern and Western United States.City Office REIT has a Zacks Rank #2 and a Value Score of A at present. CIO has a projected 3-5-year EPS growth rate of 6.0%.Based in Bad Homburg, Germany, Fresenius Medical Care is one of the largest integrated providers of products and services for individuals undergoing dialysis following chronic kidney failure. Fresenius Medical currently has a Zacks Rank #1 and a Value Score of A.FMS has a projected 3-5-year EPS growth rate of 11.9%.Headquartered in Liberty Lake, WA, Itron is a technology and services company and one of the leading global suppliers of a wide range of standard, advanced, and smart meters and meter communication systems, including networks and communication modules, software, devices, sensors, data analytics and services to the utility and municipal sectors.Itron has a Zacks Rank #2 and a Value Score of B. ITRI has a projected 3-5-year EPS growth rate of 29.0%.Headquartered in Pennsylvania, EnerSys manufactures, markets and distributes various industrial batteries worldwide. It currently has a Zacks Rank of #2. You can see the complete list of today’s Zacks #1 Rank stocks here.ENS has a Value Score of A and a projected 3-5-year EPS growth rate of 18.0%.Get the remaining stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back-testing software.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2435276/5-low-price-to-book-stocks-to-include-in-your-portfolio-for-gainsFollow us on Twitter: https://www.twitter.com/zacksresearchJoin us on Facebook: https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Itron, Inc. (ITRI): Free Stock Analysis Report Fresenius Medical Care AG & Co. KGaA (FMS): Free Stock Analysis Report Enersys (ENS): Free Stock Analysis Report JD.com, Inc. (JD): Free Stock Analysis Report City Office REIT, Inc. (CIO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: City Office REIT und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf City Office REIT
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf City Office REIT
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Fresenius SE & Co. KGaA (St.)
Analysen zu Fresenius SE & Co. KGaA (St.)
Datum | Rating | Analyst | |
---|---|---|---|
26.03.2025 | Fresenius SECo Buy | UBS AG | |
21.03.2025 | Fresenius SECo Buy | Jefferies & Company Inc. | |
14.03.2025 | Fresenius SECo Kaufen | DZ BANK | |
13.03.2025 | Fresenius SECo Overweight | JP Morgan Chase & Co. | |
05.03.2025 | Fresenius SECo Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
26.03.2025 | Fresenius SECo Buy | UBS AG | |
21.03.2025 | Fresenius SECo Buy | Jefferies & Company Inc. | |
14.03.2025 | Fresenius SECo Kaufen | DZ BANK | |
13.03.2025 | Fresenius SECo Overweight | JP Morgan Chase & Co. | |
05.03.2025 | Fresenius SECo Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
26.02.2025 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
04.02.2025 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
08.11.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
06.11.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
13.09.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
30.07.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
23.07.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
17.03.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
23.02.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius SE & Co. KGaA (St.) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen